Clinical Trial Update: Tebentafusp-tebn With LDT in Metastatic UM [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial of tebentafusp-tebn with LDT in metastatic uveal melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• KIMMTRAK (tebentafusp)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Metastatic Uveal Melanoma | Phase 1, Phase 2 | Status: RECRUITING